ATE157119T1 - Subklasse von menschlichen vorläuferzellen - Google Patents

Subklasse von menschlichen vorläuferzellen

Info

Publication number
ATE157119T1
ATE157119T1 AT91303960T AT91303960T ATE157119T1 AT E157119 T1 ATE157119 T1 AT E157119T1 AT 91303960 T AT91303960 T AT 91303960T AT 91303960 T AT91303960 T AT 91303960T AT E157119 T1 ATE157119 T1 AT E157119T1
Authority
AT
Austria
Prior art keywords
subclass
precursor cells
human precursor
stem cells
cells
Prior art date
Application number
AT91303960T
Other languages
English (en)
Inventor
Leon Terstappen
Michael Loken
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE157119T1 publication Critical patent/ATE157119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91303960T 1990-05-01 1991-05-01 Subklasse von menschlichen vorläuferzellen ATE157119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51710190A 1990-05-01 1990-05-01

Publications (1)

Publication Number Publication Date
ATE157119T1 true ATE157119T1 (de) 1997-09-15

Family

ID=24058370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91303960T ATE157119T1 (de) 1990-05-01 1991-05-01 Subklasse von menschlichen vorläuferzellen

Country Status (11)

Country Link
US (2) US5622853A (de)
EP (1) EP0455482B1 (de)
JP (1) JP3070865B2 (de)
AT (1) ATE157119T1 (de)
AU (1) AU641230B2 (de)
CA (1) CA2041258A1 (de)
DE (1) DE69127313T2 (de)
DK (1) DK0455482T3 (de)
ES (1) ES2106763T3 (de)
GR (1) GR3024783T3 (de)
IE (1) IE911145A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571714A (en) * 1988-12-22 1996-11-05 Celtrix Pharmaceuticals, Inc. Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
US5605822A (en) * 1989-06-15 1997-02-25 The Regents Of The University Of Michigan Methods, compositions and devices for growing human hematopoietic cells
US5635386A (en) 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5635387A (en) * 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5840580A (en) * 1990-05-01 1998-11-24 Becton Dickinson And Company Phenotypic characterization of the hematopoietic stem cell
CA2122141C (en) * 1991-10-23 2007-07-17 Shelly Heimfeld Methods for selectively expanding stem cells
EP0563485A1 (de) * 1992-03-30 1993-10-06 Schering-Plough In-vitro-Erzeugung von menschlichen dendritischen Zellen
US6004807A (en) * 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
DE69309487T2 (de) * 1992-11-13 1997-10-23 Univ Washington Peripheralisierung hämatopoietischer stammzellen
AU5603894A (en) * 1992-11-16 1994-06-08 Applied Immune Sciences, Inc. Pluripotential quiescent stem cell population
JPH08509859A (ja) * 1993-02-19 1996-10-22 セルトリックス ファーマシューティカルズ，インコーポレイテッド ＴＧＦ−βの中和による長期骨髄培養物における幹細胞の拡大
WO1994025047A1 (en) * 1993-05-03 1994-11-10 Genentech, Inc. Inhibition of leukocyte adhesion
US6555324B1 (en) * 1993-11-04 2003-04-29 Becton Dickinson & Company Method to distinguish hematopoietic progenitor cells
EP0662512A3 (de) * 1993-12-20 1997-01-15 Becton Dickinson Co Menschliche hämatopoietische Stammzellen.
US5972703A (en) * 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
DE69531432T2 (de) * 1994-09-23 2004-07-29 Becton Dickinson And Co. Verfahren zur Unterscheidung von granulomoncytischen Progenitoren in einer Population von CD34+ Zellen
US5874266A (en) * 1997-03-27 1999-02-23 Palsson; Bernhard O. Targeted system for removing tumor cells from cell populations
AU1457199A (en) 1997-11-12 1999-05-31 University Of Pittsburgh Isolation, characterization, and identification of dendritic like cells and methods of using same
US20020034819A1 (en) 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
WO2003050251A2 (en) 2001-12-07 2003-06-19 Geron Corporation Hematopoietic cells from human embryonic stem cells
US7799324B2 (en) 2001-12-07 2010-09-21 Geron Corporation Using undifferentiated embryonic stem cells to control the immune system
NZ534205A (en) * 2001-12-22 2006-04-28 Antibody A 4 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
US7595148B2 (en) 2003-01-25 2009-09-29 Irm Llc Methods and compositions for modulating T lymphocytes
AU2004227205B2 (en) * 2003-04-08 2010-06-10 Yeda Research And Development Co. Ltd Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
WO2005046596A2 (en) 2003-11-04 2005-05-26 University Of Maryland Baltimore Stem cell culture medium and method of using said medium and the cells
JP5805358B2 (ja) * 2005-02-02 2015-11-04 ブルース・ミルネ・ホール 特異抗原に活性化したｃｄ４＋、ｃｄ２５＋ｔ細胞
EP2422803A3 (de) 2006-03-07 2013-03-13 Geeta Shroff Zusammentsetzungen enhaltend menschliche embryonale Stammzellen und ihre Derivate, Verwendung davon und Verfahren zur ihrer Vorbereitung
US8569059B2 (en) 2006-08-02 2013-10-29 Newsouth Innovations Pty Limited Method of identifying CD4+ CD25+ T-cells activated to an antigen which express CD8
EP2359164A4 (de) * 2008-12-10 2012-05-30 Abqmr Inc Kernmagnetresonanzgerät, verfahren und zugehörige technologie
EP2454362A4 (de) * 2009-07-14 2013-02-27 Massachusetts Inst Technology Hämatopoetische stromavorläuferzellen und verwendungen davon
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
CN107599917B (zh) 2012-08-07 2020-01-17 提爱思科技股份有限公司 部件连接结构和交通工具座椅
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US10617721B2 (en) * 2013-10-24 2020-04-14 Ospedale San Raffaele S.R.L. Methods for genetic modification of stem cells

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680383A (en) * 1979-03-20 1987-07-14 Ortho Pharmaceutical Monoclonal antibody to human T cells
US4803262A (en) * 1979-10-09 1989-02-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
US4624925A (en) * 1979-12-04 1986-11-25 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods
US4798806A (en) * 1980-01-08 1989-01-17 Ortho Pharmaceutical Corporation Compositions and methods using a monoclonal antibody to a human T cell antigen
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
JPS641A (en) * 1987-03-25 1989-01-05 Nippon Ekishiyou Kk Masking of agent having strong smell
US4845653A (en) * 1987-05-07 1989-07-04 Becton, Dickinson And Company Method of displaying multi-parameter data sets to aid in the analysis of data characteristics
ATE81724T1 (de) * 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US4987086A (en) * 1987-11-30 1991-01-22 Becton, Dickinson And Company Method for analysis of subpopulations of cells
WO1989008114A1 (en) * 1988-02-25 1989-09-08 The General Hospital Corporation Rapid immunoselection cloning method
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition
US5047321A (en) * 1988-06-15 1991-09-10 Becton Dickinson & Co. Method for analysis of cellular components of a fluid
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell

Also Published As

Publication number Publication date
US5583033A (en) 1996-12-10
AU7429391A (en) 1991-11-07
JPH0576354A (ja) 1993-03-30
DK0455482T3 (da) 1998-04-06
CA2041258A1 (en) 1991-11-02
JP3070865B2 (ja) 2000-07-31
EP0455482B1 (de) 1997-08-20
US5622853A (en) 1997-04-22
AU641230B2 (en) 1993-09-16
EP0455482A2 (de) 1991-11-06
ES2106763T3 (es) 1997-11-16
GR3024783T3 (en) 1998-01-30
DE69127313D1 (de) 1997-09-25
DE69127313T2 (de) 1998-01-22
IE911145A1 (en) 1991-11-06
EP0455482A3 (en) 1992-09-02

Similar Documents

Publication Publication Date Title
ATE157119T1 (de) Subklasse von menschlichen vorläuferzellen
Ballas et al. Adult bone marrow stem cells for cell and gene therapies: implications for greater use
DE59912118D1 (de) Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen
Nauta et al. Wound healing and regenerative strategies
CY1107121T1 (el) Ρυθμιση διαφοροποιησης αιματοποιητικων βλαστικων κυτταρων με τη χρηση ανθρωπινων μεσυγχυματικων βλαστικων κυτταρων
CA2339182A1 (en) Improvement of cardiac function by mesenchymal stem cell transplantation
GT198277746A (es) Interteron inmune humano
EP0453453A4 (en) Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
SE0201328D0 (sv) Hematopoietic differentiation of human embryonic stem cells
EP1007630A4 (de) Natürliche killerzelllinien und verfahren zu ihrer verwendung
IL148008A0 (en) Conditional immortalisation of cells
NZ281482A (en) The stimulation of erythropoiesis using thrombopoietin and erythropoietin
ES2060942T3 (es) Terapia genetica utilizando celulas estromicas.
DE69129113T2 (de) Stimulierung der stroma- und vorläuferzellen im knochenmark
ATE437219T1 (de) Von monozyten stammende multipotente zelle momc
Bilko et al. Characterization of the interactions between stromal and haematopoietic progenitor cells in expansion cell culture models
ATE191501T1 (de) Verwendung von hepatocyten-wachstumsfaktoren zur herstellung eines vermehrungssystems für hematopoietische stammzellen
ATE225183T1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
Aljamie et al. Dental pulp stem cells, a new era in regenerative medicine: a literature review
ATE120491T1 (de) Ausgeglichenes, konstitutives, induzierbares transkriptionssystem.
Stripp et al. Bioengineered lung epithelium: implications for basic and applied studies in lung tissue regeneration
Ahuja et al. DENTAL STEM CELLS: MIRACLE CELLS OF DENTISTRY.
Shah Stem Cell Sources and their potential for cancer therapeutics
Palsson Hematopoietic Cells
Patel DENTAL STEM CELLS AND THEIR POTENTIAL ROLE IN REGENRATIVE DENTISTRY

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee